MAX Chat
Company Analysis Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited
1. Summary
Advantages
- Dividends (5.38%) are higher than the sector average (2.97%).
- The company's current efficiency (ROE=7.4%) is higher than the sector average (ROE=-5.11%)
Disadvantages
- Price (18.41 HK$) is higher than fair price (18.16 HK$)
- The stock's return over the last year (2.39%) is lower than the sector average (32.31%).
- Current debt level 15.15% has increased over 5 years from 10.32%.
Similar companies
2. Share price and performance
2.1. Share price
2.3. Market efficiency
| Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited | Healthcare | Index | |
|---|---|---|---|
| 7 days | 1.7% | -1.7% | 1.8% |
| 90 days | 4.7% | 47.5% | 14.2% |
| 1 year | 2.4% | 32.3% | 47.4% |
0874 vs Sector: Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited has significantly underperformed the "Healthcare" sector by -29.92% over the past year.
0874 vs Market: Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited has significantly underperformed the market by -44.97% over the past year.
Stable price: 0874 is not significantly more volatile than the rest of the market on "Hong Kong Exchanges" over the last 3 months, with typical variations of +/- 5% per week.
Long period: 0874 with weekly volatility of 0.046% over the past year.
3. Summary of the report
4. Fundamental Analysis
4.1. Stock price and price forecast
Above fair price: The current price (18.41 HK$) is higher than the fair price (18.16 HK$).
Price is higher than fair: The current price (18.41 HK$) is 1.4% higher than the fair price.
4.2. P/E
P/E vs Sector: The company's P/E (10.4) is higher than that of the sector as a whole (-27.77).
P/E vs Market: The company's P/E (10.4) is lower than that of the market as a whole (23.3).
4.2.1 P/E Similar companies
4.3. P/BV
P/BV vs Sector: The company's P/BV (0.7338) is lower than that of the sector as a whole (3.06).
P/BV vs Market: The company's P/BV (0.7338) is lower than that of the market as a whole (2.59).
4.3.1 P/BV Similar companies
4.4. P/S
P/S vs Sector: The company's P/S indicator (0.3933) is lower than that of the sector as a whole (54.94).
P/S vs Market: The company's P/S indicator (0.3933) is lower than that of the market as a whole (19.57).
4.4.1 P/S Similar companies
4.5. EV/Ebitda
EV/Ebitda vs Sector: The company's EV/Ebitda (4.74) is lower than that of the sector as a whole (28.92).
EV/Ebitda vs Market: The company's EV/Ebitda (4.74) is lower than that of the market as a whole (37.51).
5. Profitability
5.1. Profitability and revenue
5.2. Earnings per share - EPS
5.3. Past profitability Net Income
Yield Trend: Negative and has fallen by -2.03% over the last 5 years.
Accelerating profitability: The return for the last year (0.3831%) exceeds the average return for 5 years (-2.03%).
Profitability vs Sector: The return for the last year (0.3831%) is lower than the return for the sector (2.95%).
5.4. ROE
ROE vs Sector: The company's ROE (7.4%) is higher than that of the sector as a whole (-5.11%).
ROE vs Market: The company's ROE (7.4%) is higher than that of the market as a whole (-4.45%).
5.5. ROA
ROA vs Sector: The company's ROA (3.27%) is higher than that of the sector as a whole (0.2788%).
ROA vs Market: The company's ROA (3.27%) is higher than that of the market as a whole (2.7%).
5.6. ROIC
ROIC vs Sector: The company's ROIC (0%) is lower than that of the sector as a whole (0%).
ROIC vs Market: The company's ROIC (0%) is lower than that of the market as a whole (14.67%).
7. Dividends
7.1. Dividend yield vs Market
High yield: The dividend yield of the company 5.38% is higher than the average for the sector '2.97%.
7.2. Stability and increase in payments
Dividend stability: The company's dividend yield 5.38% has been steadily paid over the past 7 years, DSI=1.
Dividend growth: Company's dividend yield 5.38% has been growing over the last 5 years. Growth over 7 years.
7.3. Payout percentage
Dividend Coverage: Current payments from income (79.38%) are at a comfortable level.
Pay for your subscription
More functionality and data for company and portfolio analysis is available by subscription
